Related Experiment Video
Updated: Jun 27, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Heberden's Angina-Pathophysiology and Treatment
1Division of Cardiology, Department of Medicine, University of California, San Francisco.
Insights
This seminar reviews chronic angina pectoris, covering diagnosis, pathophysiology, and evidence-based therapies. It also explores new treatments and non-pharmacologic interventions for managing this heart condition.
Area of Science:
- Cardiology
- Internal Medicine
Background:
- Chronic angina pectoris is a significant cardiovascular condition characterized by chest pain due to myocardial ischemia.
- Understanding the pathophysiology of effort angina is crucial for effective management.
Purpose of the Study:
- To provide a comprehensive overview of chronic angina pectoris.
- To review current and emerging therapeutic strategies.
- To discuss non-pharmacologic interventions.
Main Methods:
- Review of published clinical trials on angina therapies.
- Discussion of pathophysiologic mechanisms of effort angina.
- Presentation of investigational agents and non-pharmacologic interventions.
Main Results:
- Evidence-based therapies for angina include those preventing myocardial infarction and death, and those reducing symptoms and ischemia.
- Newer agents show potential for refractory angina.
- Non-pharmacologic interventions offer additional management options.
Conclusions:
- Effective management of chronic angina pectoris involves a multi-faceted approach.
- Therapies should be tailored to prevent adverse cardiac events and alleviate symptoms.
- Investigational and non-pharmacologic options expand treatment possibilities for refractory cases.
Abstract:
This seminar provides an overview of chronic angina pectoris. First, the differential diagnosis of chronic angina pectoris is described. The basic pathophysiology of effort angina, including coronary flow physiology as well as the factors that contribute to supply-demand mismatch are discussed. The authors review the published trials that provide the evidence on which angina therapies are based, identifying those treatments that prevent myocardial infarction and death and those that reduce symptoms and ischemia. Newer and investigational agents which can potentially benefit patients with refractory angina are presented. Finally, non-pharmacologic interventions for chronic angina are reviewed.
Related Concept Videos
Angina IV: Management
Angina V: Nursing Management
Angina I: Introduction
Angina II: Classification
Angina III: Clinical Manifestations and Assessment
Rheumatic Heart Disease III: Medical Management

